Table 3.
Univariate (mOR) conditional regression analysis
mOR | 95 % CI | P | |
---|---|---|---|
Vaccinations in 6 weeks before index date | |||
Seasonal influenza vaccination 2010–2011 | 3.9 | 1.6–9.9 | 0.004 |
Other vaccinations | 3.5 | 0.2–55.8 | 0.38 |
Infections in 6 weeks before index date | |||
Influenza-like illness (ILI) | 8.7 | 4.2–18.3 | <0.001 |
Upper respiratory tract infection (URI) | 4.1 | 2.2–7.7 | <0.001 |
Gastrointestinal infection (GI) | 12.3 | 4.7–32.2 | <0.001 |
Chronic comorbidity | |||
Malignancy | 1.2 | 0.6–2.4 | 0.65 |
Immunocompromised | 6.1 | 1.6–23.3 | 0.008 |
Autoimmune disorders | 2.7 | 1.1–7.0 | 0.035 |
Epstein-Barr virus | 2.2 | 0.7–6.4 | 0.15 |
Other conditions in 6 months before index date | |||
Surgery | 1.0 | 0.4–2.5 | 0.98 |
Influenza-like illness (ILI) | 4.1 | 2.3–7.1 | <0.001 |
Upper respiratory tract infection (URI) | 2.7 | 1.6–4.7 | <0.001 |
Gastrointestinal infection (GI) | 5.9 | 2.9–11.8 | <0.001 |
Vaccination | |||
Seasonal influenza vaccination 2010–2011 | 1.6 | 0.9–2.7 | 0.12 |
Seasonal influenza vaccination >6 weeks | 0.9 | 0.4–1.6 | 0.64 |
Other vaccinations | 1.0 | 0.2–5.6 | 0.98 |